Page last updated: 2024-08-23

methyldopa and Movement Disorders

methyldopa has been researched along with Movement Disorders in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (86.96)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (8.70)	29.6817
2010's	1 (4.35)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, R; Jackson, MJ; Jenner, P; Rose, S; Tayarani-Binazir, KA; Zoubiane, G	1
CLARK, WG; MARKHAM, CH; WINTERS, WD	1
Jankovic, J	1
Metzel, E; Tzavellas, O; Umbach, W	2
Iwakawa, Y; Kohyama, J; Shimohira, M	1
Linnoila, M; Viukari, M	1
Feigenson, JS; McDowell, FH; Sweet, RD	1
Clyne, KE; Juhl, R	1
Cotzias, GC; Gellene, R; Papavasiliou, PS	1
Böszörményi, Z; Villeneuve, A	1
Curzon, G	1
Hartmann-von Monakow, K	1
Constantinidis, J	1
Calne, DB; Reid, JL	1
McDowell, FH; Sweet, RD	1
Allen, JG; Calne, DB; Davies, CA; Reid, JL; Vakil, SD	1
Cole, JO; Kazamatsuri, H	1
Duvoisin, RC; Marsden, CD	1
Fahn, S	1
Albert, ML; Yamadori, A	1
Böszörményi, Z; Deschambault, M; Lachance, R; Villeneuve, A	1
Holldorf, A; Metzel, A; Umbach, W	1

Reviews

3 review(s) available for methyldopa and Movement Disorders

Article	Year
Parkinson's disease and movement disorders: moving forward. The Lancet. Neurology, 2008, Volume: 7, Issue:1 Topics: Dopamine Agonists; Humans; Methyldopa; Movement Disorders; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes	2008
The biochemistry of dyskinesias. International review of neurobiology, 1967, Volume: 10 Topics: Acetylcholine; Animals; Catecholamines; Cats; Copper; Dihydroxyphenylalanine; Dogs; Hepatolenticular Degeneration; Humans; Huntington Disease; Manganese Poisoning; Melanins; Metals; Methyldopa; Movement Disorders; Parkinson Disease; Phenothiazines; Rabbits; Rats; Reserpine; Serotonin; Telencephalon; Tremorine	1967
Antiparkinsonian drugs: pharmacological and therapeutic aspects. Drugs, 1972, Volume: 4, Issue:1 Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission	1972

Trials

4 trial(s) available for methyldopa and Movement Disorders

Article	Year
Effect of methyldopa on tardive dyskinesia in psychogeriatric patients. Current therapeutic research, clinical and experimental, 1975, Volume: 18, Issue:3 Topics: Aged; Clinical Trials as Topic; Dementia; Female; Humans; Male; Methyldopa; Movement Disorders; Muscle Rigidity; Spasm; Tremor	1975
Modification of Parkinsonism--chronic treatment with L-dopa. The New England journal of medicine, 1969, Feb-13, Volume: 280, Issue:7 Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blood-Brain Barrier; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Feeding and Eating Disorders; Female; Humans; Huntington Disease; Male; Manganese; Mental Processes; Methyldopa; Middle Aged; Movement Disorders; Nausea; Neurologic Manifestations; Parkinson Disease; Phenylacetates; Placebos; Thyroid Function Tests; Tyrosine; Vomiting	1969
Treatment of drug-induced dyskinesias. Lancet (London, England), 1970, Feb-14, Volume: 1, Issue:7642 Topics: Aged; Dihydroxyphenylalanine; Humans; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Reserpine	1970
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase. Journal of the neurological sciences, 1972, Volume: 17, Issue:1 Topics: Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hydrazines; Male; Methyldopa; Movement Disorders; Parkinson Disease	1972

Other Studies

16 other study(ies) available for methyldopa and Movement Disorders

Article	Year
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset. European journal of pharmacology, 2010, Jun-10, Volume: 635, Issue:1-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Callithrix; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Levodopa; Male; Methyldopa; Motor Activity; Movement Disorders	2010
EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS. Life sciences (1962), 1963, Volume: 9 Topics: Adolescent; Chorea; Dystonia Musculorum Deformans; Dystonic Disorders; Genetic Diseases, X-Linked; Humans; Huntington Disease; Methyldopa; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Torticollis; Tremor	1963
[On the efficacy of alpha-methyldopa in hyperkinesia]. Deutsche medizinische Wochenschrift (1946), 1967, Jun-09, Volume: 92, Issue:23 Topics: Electroencephalography; Humans; Methyldopa; Movement Disorders; Skin Tests	1967
Rapid-eye-movement sleep in jittery infants. Early human development, 2002, Volume: 66, Issue:1 Topics: Female; Haloperidol; Humans; Infant; Male; Maternal-Fetal Exchange; Methyldopa; Movement Disorders; Pregnancy; Reserpine; Sleep, REM	2002
Piribedil: its synergistic effect in multidrug regimens for parkinsonism. Neurology, 1976, Volume: 26, Issue:5 Topics: Aged; Amantadine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Piperazines; Piribedil	1976
Tardive dyskinesia. American journal of hospital pharmacy, 1976, Volume: 33, Issue:5 Topics: Choline; Deanol; Dopamine Antagonists; Haloperidol; Humans; Methyldopa; Movement Disorders; Papaverine; Parasympathomimetics; Reserpine; Tetrabenazine	1976
[Specific therapy of extrapyramidal-motor syndromes]. Bibliotheca psychiatrica et neurologica, 1969, Volume: 139 Topics: Analgesics; Athetosis; Chorea; Datura stramonium; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Extrapyramidal Tracts; Female; Humans; Huntington Disease; Methyldopa; Movement Disorders; Myoclonus; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Phenothiazines; Physical Therapy Modalities; Phytotherapy; Plants, Medicinal; Plants, Toxic; Pregnancy; Pyridoxine; Reserpine; Scopolamine; Stereotaxic Techniques; Tranquilizing Agents	1969
[Monoamines and choreic syndromes]. Revue neurologique, 1972, Volume: 127, Issue:1 Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine	1972
The "on-off" response to chronic L-DOPA treatment of Parkinsonism. Advances in neurology, 1974, Volume: 5 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Confusion; Dietary Proteins; Enzyme Inhibitors; Female; Gait; Humans; Levodopa; Male; Methyldopa; Movement Disorders; Muscle Cramp; Parkinson Disease; Time Factors	1974
Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa. Archives of general psychiatry, 1972, Volume: 27, Issue:6 Topics: Basal Ganglia Diseases; Blood Pressure; Evaluation Studies as Topic; Female; Humans; Male; Methyldopa; Middle Aged; Movement Disorders; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents	1972
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi. Brain research, 1974, May-10, Volume: 71, Issue:1 Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Methyldopa; Mice; Movement Disorders; Parkinson Disease; Phenoxybenzamine; Pimozide; Reserpine	1974
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology, 1974, Volume: 24, Issue:5 Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine	1974
Involuntary movement disorder caused by methyldopa. The New England journal of medicine, 1972, Mar-16, Volume: 286, Issue:11 Topics: Athetosis; Chorea; Humans; Male; Methyldopa; Middle Aged; Movement Disorders	1972
[Attempt at treatment of permanent type of post-neuroleptic dyskinesia]. Laval medical, 1970, Volume: 41, Issue:7 Topics: Aged; Female; Humans; Male; Methyldopa; Middle Aged; Movement Disorders; Reserpine; Tranquilizing Agents	1970
The clinical effect of catecholamine-blocking drugs (alpha-methyldopa, propanolol) in patients with hyperkinetic disorders. Confinia neurologica, 1967, Volume: 29, Issue:2 Topics: Electroencephalography; Electromyography; Humans; Methyldopa; Movement Disorders; Propranolol	1967
The effect of methyldopa on the excretion of catecholamines in patients with extrapyramidal disorders. Confinia neurologica, 1967, Volume: 29, Issue:2 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Mandelic Acids; Methyldopa; Movement Disorders; Norepinephrine; Phenylacetates	1967